Defining response profiles after alemtuzumab: Rare paradoxical disease exacerbation

Heinz Wiendl, Peter A. Calabresi, Sven G. Meuth

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)309-311
Number of pages3
JournalNeurology
Volume90
Issue number7
DOIs
StatePublished - Feb 13 2018

ASJC Scopus subject areas

  • Clinical Neurology

Cite this